News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

Study Status:

Study Closed

Contact Information:

(956) 362-2391

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The purpose of the TESLA study is establish the effectiveness of
intra-arterial treatment (IAT). Patients presenting with symptoms of
arterial ischemic stroke who have evidence of a moderate-large
infarct volume [NCCT ASPECTS 2-5] in the anterior circulation will be
assigned to either best medical management alone (including IV
rtPA) or intra-arterial treatment (IAT) with mechanical
thrombectomy added to best medical management. Each treated
patient will be followed and assessed for 3 months after


Principal Investigator
Patricia Fernandez, M.D.
Esmeralda Cordoso-Mendoza
Mercy Health Ohio
Type of Trial
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram